Exomas

Argentina
Rosario, Santa Fe, Argentina, 2000

Company profile

Exomas company profile

Exomas develops disruptive solutions based on exosomes derived from neural stem cells for the preventive or regenerative treatment of nervous tissue affected by neurodegenerative diseases. These exosomes have the ability to induce the proliferation of neural stem cells and their differentiation into functional neurons, thus exerting a neuroregenerative effect on the affected tissue.

Business identity

Contact email
[email protected]
Phone number
3415069897
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2023-01-05

Headquarters

Postal code
2000
Country code
AR
Continent
South America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$250,000
Last funding
Grant / $31,136 / 2025-07-18
Last equity funding
Pre Seed / $250,000
Investors
2
Lead investors
2
Founders
2

Founders and investors

Founders

Claudia BanchioHUGO GRAMAJO

Lead investors

SF500Start-Up Chile

Investors

SF500Start-Up Chile